book a demo
Our Microfluidic Diffusional Sizing (MDS) Technology exploits the unique properties of flow in microfluidic channels to help researchers uncover new insights into how proteins interact and described as a breakthrough hailed as “a game-changer” by leading scientists.
‘[MDS] is the breakthrough that gives us invaluable new insights & could be a game-changer for our ability to understand, diagnose & treat COVID-19’
‘[MDS] provided an unprecedented level of granularity to identify the mode of action by which SARS-CoV-2 variants spike escape humoral immune response’
‘[MDS] allowed us to obtain unique information that helped us elucidate, for the first time, key differences between the way that four anti-Abeta antibody therapeutics bind to different forms of their targets’
even in complex backgrounds or with challenging targets